374 related articles for article (PubMed ID: 28069701)
21. Localized Prox1 Regulates Aortic Valve Endothelial Cell Diversity and Extracellular Matrix Stratification in Mice.
O'Donnell A; Gonzalez BA; Mukherjee S; Wilson R; Alfieri CM; Swoboda CO; Millay DP; Zorn AM; Yutzey KE
Arterioscler Thromb Vasc Biol; 2023 Aug; 43(8):1478-1493. PubMed ID: 37381982
[TBL] [Abstract][Full Text] [Related]
22. Developmental basis for filamin-A-associated myxomatous mitral valve disease.
Sauls K; de Vlaming A; Harris BS; Williams K; Wessels A; Levine RA; Slaugenhaupt SA; Goodwin RL; Pavone LM; Merot J; Schott JJ; Le Tourneau T; Dix T; Jesinkey S; Feng Y; Walsh C; Zhou B; Baldwin S; Markwald RR; Norris RA
Cardiovasc Res; 2012 Oct; 96(1):109-19. PubMed ID: 22843703
[TBL] [Abstract][Full Text] [Related]
23. Myxomatous transformation of the aortic and mitral valve with subaortic "sail-like" membrane.
Jamshidi A; Klein-Robbenhaar J
Am J Med; 1970 Jul; 49(1):114-7. PubMed ID: 5431473
[No Abstract] [Full Text] [Related]
24. Echocardiographic versus histologic findings in Marfan syndrome.
Gu X; He Y; Li Z; Han J; Chen J; Nixon JV
Tex Heart Inst J; 2015 Feb; 42(1):30-4. PubMed ID: 25873795
[TBL] [Abstract][Full Text] [Related]
25. Comparative pathology of human and canine myxomatous mitral valve degeneration: 5HT and TGF-β mechanisms.
Oyama MA; Elliott C; Loughran KA; Kossar AP; Castillero E; Levy RJ; Ferrari G
Cardiovasc Pathol; 2020; 46():107196. PubMed ID: 32006823
[TBL] [Abstract][Full Text] [Related]
26. Modulation of transforming growth factor-β signaling and extracellular matrix production in myxomatous mitral valves by angiotensin II receptor blockers.
Geirsson A; Singh M; Ali R; Abbas H; Li W; Sanchez JA; Hashim S; Tellides G
Circulation; 2012 Sep; 126(11 Suppl 1):S189-97. PubMed ID: 22965982
[TBL] [Abstract][Full Text] [Related]
27. Myxomatous degeneration of cardiac valves.
Aslam PA; Eastridge CE; Bernhardt H; Pate JW
Chest; 1970 Jun; 57(6):535-9. PubMed ID: 5509633
[No Abstract] [Full Text] [Related]
28. Disrupted Slit-Robo signalling results in membranous ventricular septum defects and bicuspid aortic valves.
Mommersteeg MT; Yeh ML; Parnavelas JG; Andrews WD
Cardiovasc Res; 2015 Apr; 106(1):55-66. PubMed ID: 25691540
[TBL] [Abstract][Full Text] [Related]
29. Developmental origins for semilunar valve stenosis identified in mice harboring congenital heart disease-associated
LaHaye S; Majumdar U; Yasuhara J; Koenig SN; Matos-Nieves A; Kumar R; Garg V
Dis Model Mech; 2019 Jun; 12(6):. PubMed ID: 31138536
[TBL] [Abstract][Full Text] [Related]
30. Epicardial deletion of Sox9 leads to myxomatous valve degeneration and identifies Cd109 as a novel gene associated with valve development.
Harvey AB; Wolters RA; Deepe RN; Tarolli HG; Drummond JR; Trouten A; Zandi A; Barth JL; Mukherjee R; Romeo MJ; Vaena SG; Tao G; Muise-Helmericks R; Ramos PS; Norris RA; Wessels A
J Mol Cell Cardiol; 2024 Jan; 186():16-30. PubMed ID: 37935281
[TBL] [Abstract][Full Text] [Related]
31. Quadricuspid Aortic Valve Associated with Aortic Regurgitation, Mitral Regurgitation, and Aortic Dilatation.
Sivri S; Bastug S; Can Guney M; Alsancak Y; Ozdemir E; Bozkurt E
J Heart Valve Dis; 2017 Mar; 26(2):243-246. PubMed ID: 28820561
[TBL] [Abstract][Full Text] [Related]
32. Axin2 controls bone remodeling through the beta-catenin-BMP signaling pathway in adult mice.
Yan Y; Tang D; Chen M; Huang J; Xie R; Jonason JH; Tan X; Hou W; Reynolds D; Hsu W; Harris SE; Puzas JE; Awad H; O'Keefe RJ; Boyce BF; Chen D
J Cell Sci; 2009 Oct; 122(Pt 19):3566-78. PubMed ID: 19737815
[TBL] [Abstract][Full Text] [Related]
33. Early Activation of Growth Pathways in Mitral Leaflets Exposed to Aortic Regurgitation: New Insights from an Animal Model.
Marsit O; Royer O; Drolet MC; Arsenault M; Couet J; Morin S; Levine RA; Pibarot P; Beaudoin J
J Heart Valve Dis; 2017 May; 26(3):281-289. PubMed ID: 29092112
[TBL] [Abstract][Full Text] [Related]
34. Nkd1 functions downstream of Axin2 to attenuate Wnt signaling.
Bell I; Khan H; Stutt N; Horn M; Hydzik T; Lum W; Rea V; Clapham E; Hoeg L; Van Raay TJ
Mol Biol Cell; 2024 Jul; 35(7):ar93. PubMed ID: 38656801
[TBL] [Abstract][Full Text] [Related]
35. Reduced sox9 function promotes heart valve calcification phenotypes in vivo.
Peacock JD; Levay AK; Gillaspie DB; Tao G; Lincoln J
Circ Res; 2010 Mar; 106(4):712-9. PubMed ID: 20056916
[TBL] [Abstract][Full Text] [Related]
36. Activation of the Interleukin-33/ST2 Pathway Exerts Deleterious Effects in Myxomatous Mitral Valve Disease.
Garcia-Pena A; Ibarrola J; Navarro A; Sadaba A; Tiraplegui C; Garaikoetxea M; Arrieta V; Matilla L; Fernández-Celis A; Sadaba R; Alvarez V; Gainza A; Jover E; López-Andrés N
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33669101
[TBL] [Abstract][Full Text] [Related]
37. Autocrine serotonin and transforming growth factor beta 1 signaling mediates spontaneous myxomatous mitral valve disease.
Disatian S; Orton EC
J Heart Valve Dis; 2009 Jan; 18(1):44-51. PubMed ID: 19301552
[TBL] [Abstract][Full Text] [Related]
38. A1CF-Axin2 signal axis regulates apoptosis and migration in Wilms tumor-derived cells through Wnt/β-catenin pathway.
Ni D; Liu J; Hu Y; Liu Y; Gu Y; Zhou Q; Xie Y
In Vitro Cell Dev Biol Anim; 2019 Apr; 55(4):252-259. PubMed ID: 30825095
[TBL] [Abstract][Full Text] [Related]
39. Mesenchymal Wnt signaling promotes formation of sternum and thoracic body wall.
Snowball J; Ambalavanan M; Cornett B; Lang R; Whitsett J; Sinner D
Dev Biol; 2015 May; 401(2):264-75. PubMed ID: 25727890
[TBL] [Abstract][Full Text] [Related]
40. Lawsonia intracellularis exploits β-catenin/Wnt and Notch signalling pathways during infection of intestinal crypt to alter cell homeostasis and promote cell proliferation.
Huan YW; Bengtsson RJ; MacIntyre N; Guthrie J; Finlayson H; Smith SH; Archibald AL; Ait-Ali T
PLoS One; 2017; 12(3):e0173782. PubMed ID: 28323899
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
